[DOI] [PubMed] [Google Scholar] 35.Damholt B., Golor G., Wierich W., Pedersen P., Ekblom M., Zdravkovic M
More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected
NCHPTH remains underdiagnosed and is often associated with structural compromise of bone, namely osteoporosis and fragility fractures
Other notable adverse effects include: Injection site reactions such as erythema, pruritus, or swelling Fatigue reported in approximately 5% to 6% of patients Hypoglycemia when used in combination with insulin or sulfonylureas Increased heart rate with modest elevations of 2 to 4 beats per minute (a class effect of incretin therapies with uncertain clinical significance) Serious but rare adverse effects include acute pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), acute kidney injury (typically secondary to dehydration from gastrointestinal symptoms), and hypersensitivity reactions